Ensuring⁢ Authenticity⁣ of the International Patient Summary‍ with Digital Signatures

⁤ ⁢ Updated June 02, 2025
⁣

the International Patient Summary (IPS) is gaining traction as a vital document ⁣in ⁤healthcare. Defined using both CDA and FHIR standards, the ‍FHIR Document ⁤is especially⁣ popular.While ⁣technically⁤ equivalent, FHIR is favored for itS⁢ modern approach. The IPS facilitates document‍ sharing through various methods, including email and uploads.

However, a key question ‍arises: How can users verify ⁢the authenticity of an IPS upon receipt? While trust in ⁣transport methods and the assumption of patient⁢ honesty play‍ a role, potential risks exist. Intermediaries, whether trusted or ⁣malicious, coudl alter the content during transit. Unlike secure transports, neither CDA nor ⁢FHIR documents inherently possess⁤ integrity ‍checks, making them vulnerable to modification.

Digital signatures ⁣offer a solution by providing end-to-end authenticity proof. These signatures use cryptographic algorithms ⁣to⁢ mathematically verify that the received content matches the signed content. While they don’t prevent viewing, copying, or removal, they enable validation. FHIR R4 includes signature datatypes, but practical experience is⁢ limited, and a defined method for‍ signing FHIR‍ Documents is still under development, with improvements ⁣expected in FHIR R6.

The ‍IHE Document Digital Signature (DSG) ⁤profile offers⁤ a versatile solution for signing various document types, including CDA and FHIR. Compatible with IHE Document Sharing, DSG uses XML or JSON signatures. The signature technology remains independent of the ⁣signed document’s technology, ‍allowing versatility⁤ in signing methods. When using Document Sharing, signatures can be found via a SIGN association and validated against the received document.

DSG also supports enveloping‍ the document, useful when Document Sharing ⁣isn’t employed. This method combines the signature and document⁢ into a single object, reducing‍ the risk of accidental loss. Though, accessing the document requires extracting it from the envelope, complicating its use.

While signing documents is relatively straightforward, validating signatures presents challenges. Crucially, validation requires checking ⁤the timestamp and ensuring the signing certificate was valid at that time. This necessitates‍ a PKI designed for long-term certificate validation, unlike typical TLS ⁣certificates.

Governance plays a vital role in both signing ⁤and validating IPS documents. Factors to consider include the meaning of the signature, the format used, and‍ the encoding of the IPS. Converting the IPS can break⁤ signatures, so‍ signing the recipient’s encoding form is essential.

Governance is also needed for handling received IPS documents. Policies should address processing unsigned IPS documents,‍ warning users about missing ⁤signatures, and validating signatures only when necessary, such as during legal challenges. clear guidelines are needed for handling invalid signatures, including whether to process the IPS or not.

Modifications to the IPS will ⁢break the signature. ⁤Though, authorized modifications can ‍be supported through IHE Document Sharing, where the original document remains accessible and the modification is⁣ associated with ⁤it. Alternatively, trusting the authorized modifier, who validates the original signature and applies a new signature to the modified content, can ensure authenticity.

What’s next

While digital signature technology is mature, its widespread adoption faces hurdles due to the complexity and cost of⁤ infrastructure and governance. Overcoming ⁢these challenges is essential to fully⁢ realize the benefits of digital signatures in ensuring the authenticity of the International Patient⁤ Summary and maintaining data integrity.